View in EDS HTML Full Text PDF Full Text

Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.

Saved in:
Bibliographic Details
Title: Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.
Authors: Green ML; Certara Strategic Consulting, Menlo Park, CA, USA., Ma SC; Certara Strategic Consulting, Menlo Park, CA, USA., Goble S; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Giordano H; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Maloney L; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Simmons AD; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Beltman J; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Harding TC; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Xiao JJ; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA. jxiao@clovisoncology.com.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 671-682. Date of Electronic Publication: 2022 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35397664
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Green+ML%22">Green ML</searchLink>; Certara Strategic Consulting, Menlo Park, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ma+SC%22">Ma SC</searchLink>; Certara Strategic Consulting, Menlo Park, CA, USA.<br /><searchLink fieldCode="AU" term="%22Goble+S%22">Goble S</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Giordano+H%22">Giordano H</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Maloney+L%22">Maloney L</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Simmons+AD%22">Simmons AD</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Beltman+J%22">Beltman J</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+JJ%22">Xiao JJ</searchLink>; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA. jxiao@clovisoncology.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 671-682. <i>Date of Electronic Publication: </i>2022 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35397664
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-022-04413-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 671
    Titles:
      – TitleFull: Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Green ML
      – PersonEntity:
          Name:
            NameFull: Ma SC
      – PersonEntity:
          Name:
            NameFull: Goble S
      – PersonEntity:
          Name:
            NameFull: Giordano H
      – PersonEntity:
          Name:
            NameFull: Maloney L
      – PersonEntity:
          Name:
            NameFull: Simmons AD
      – PersonEntity:
          Name:
            NameFull: Beltman J
      – PersonEntity:
          Name:
            NameFull: Harding TC
      – PersonEntity:
          Name:
            NameFull: Xiao JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 89
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1